Cargando…
Nesfatin-1 alleviates high glucose/high lipid-induced injury of trophoblast cells during gestational diabetes mellitus
Gestational diabetes mellitus (GDM) is a common disease in pregnant women, imposing risks on both mother and fetus. Dysregulated nesfatin-1 has been observed in women with GDM, but the specific role of nesfatin-1 underlying the pathological process of GDM is unclear. The main objective of this study...
Autores principales: | He, Huanling, Liu, Yingyu, Sun, Minghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810041/ https://www.ncbi.nlm.nih.gov/pubmed/34895049 http://dx.doi.org/10.1080/21655979.2021.2001205 |
Ejemplares similares
-
Nesfatin-1 and Vaspin as Potential Novel Biomarkers for the Prediction and Early Diagnosis of Gestational Diabetes Mellitus
por: Mierzyński, Radzisław, et al.
Publicado: (2019) -
Circulating FABP4, nesfatin-1, and osteocalcin concentrations in women with gestational diabetes mellitus: a meta-analysis
por: Sun, Jianran, et al.
Publicado: (2020) -
Differential Expression of miR-136 in Gestational Diabetes Mellitus Mediates the High-Glucose-Induced Trophoblast Cell Injury through Targeting E2F1
por: Zhang, Chunxia, et al.
Publicado: (2020) -
High serum triglyceride levels in the early first trimester of pregnancy are associated with gestational diabetes mellitus: A prospective cohort study
por: Zhu, Haiyan, et al.
Publicado: (2020) -
Maternal Serum Delta-Like 1 and Nesfatin-1 Levels in Gestational Diabetes Mellitus: A Prospective Case-Control Study
por: Demir Çaltekin, Melike, et al.
Publicado: (2021)